Repeated courses of escalating doses of Nivolumab in refractory Hodgkin lymphoma with recurrent relapses post allografting: A safe and effective treatment approach

For patients with Hodgkin Lymphoma (HL) who experience relapse post allogeneic stem cell transplantation, limited treatment options exist, and the ultimate outcome is poor. Recently, the programmed cell death protein-1 (PD-1) inhibitors have shown remarkable efficacy in patients with refractory/rela...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Hematol Rep
Prif Awduron: Kaloyannidis, Panayotis, Al Shaibani, Eshrak, Moinnudin, Asif, Al Anezi, Khalid, Al Hashmi, Hani
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: PAGEPress Publications, Pavia, Italy 2021
Pynciau:
Case Report
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7967268/
https://ncbi.nlm.nih.gov/pubmed/33747411
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/hr.2021.8780
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg